Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia
Sponsor: Universidade Federal Fluminense
Summary
The study aims to evaluate the effect of the nattokinase enzyme on inflammation and markers of cardiovascular risk in participants with dyslipidemia. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants with dyslipidemia for two months.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2024-08-03
Completion Date
2026-07-31
Last Updated
2025-04-04
Healthy Volunteers
No
Interventions
Nattokinase
Participants will receive 1 capsule per day, providing the active nattokinase daily, at a dosage of 100mg, standardized at 2,000 Fibrinolytic Units for 2 months
Placebo
The placebo group will receive 1 capsule per day with 100mg containing corn starch for 2 months.
Locations (1)
Denise Mafra
Rio de Janeiro, Brazil